Microbot Medical (MBOT) Competitors $2.97 +0.23 (+8.39%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$3.04 +0.07 (+2.36%) As of 07/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MBOT vs. OM, CLPT, RXST, NPCE, SNWV, NNOX, CATX, DRTS, NYXH, and XAIRShould you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include Outset Medical (OM), ClearPoint Neuro (CLPT), RxSight (RXST), NeuroPace (NPCE), Sanuwave Health (SNWV), Nano-X Imaging (NNOX), Perspective Therapeutics (CATX), Alpha Tau Medical (DRTS), Nyxoah (NYXH), and Beyond Air (XAIR). These companies are all part of the "medical equipment" industry. Microbot Medical vs. Its Competitors Outset Medical ClearPoint Neuro RxSight NeuroPace Sanuwave Health Nano-X Imaging Perspective Therapeutics Alpha Tau Medical Nyxoah Beyond Air Microbot Medical (NASDAQ:MBOT) and Outset Medical (NASDAQ:OM) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation. Do institutionals and insiders believe in MBOT or OM? 16.3% of Microbot Medical shares are owned by institutional investors. 4.7% of Microbot Medical shares are owned by company insiders. Comparatively, 2.4% of Outset Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts recommend MBOT or OM? Microbot Medical presently has a consensus target price of $9.00, indicating a potential upside of 203.03%. Outset Medical has a consensus target price of $29.50, indicating a potential upside of 59.20%. Given Microbot Medical's higher probable upside, equities research analysts clearly believe Microbot Medical is more favorable than Outset Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Microbot Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Outset Medical 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has preferable earnings & valuation, MBOT or OM? Microbot Medical has higher earnings, but lower revenue than Outset Medical. Microbot Medical is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMicrobot MedicalN/AN/A-$11.44M-$0.65-4.57Outset Medical$115.27M2.85-$127.98M-$29.15-0.64 Does the media refer more to MBOT or OM? In the previous week, Microbot Medical had 2 more articles in the media than Outset Medical. MarketBeat recorded 4 mentions for Microbot Medical and 2 mentions for Outset Medical. Outset Medical's average media sentiment score of 1.77 beat Microbot Medical's score of 0.65 indicating that Outset Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Microbot Medical 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Outset Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is MBOT or OM more profitable? Microbot Medical has a net margin of 0.00% compared to Outset Medical's net margin of -98.74%. Microbot Medical's return on equity of -110.27% beat Outset Medical's return on equity.Company Net Margins Return on Equity Return on Assets Microbot MedicalN/A -110.27% -94.20% Outset Medical -98.74%-143.62%-37.50% Which has more risk and volatility, MBOT or OM? Microbot Medical has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Comparatively, Outset Medical has a beta of 2.15, meaning that its stock price is 115% more volatile than the S&P 500. SummaryMicrobot Medical beats Outset Medical on 8 of the 15 factors compared between the two stocks. Get Microbot Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBOT vs. The Competition Export to ExcelMetricMicrobot MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$99.68M$6.85B$5.70B$9.51BDividend YieldN/A1.27%4.69%4.01%P/E Ratio-4.5725.4528.1020.06Price / SalesN/A64.10429.1688.51Price / CashN/A20.5536.2258.56Price / Book17.474.758.665.87Net Income-$11.44M$176.14M$3.25B$258.55M7 Day Performance20.24%2.92%4.22%3.73%1 Month Performance19.28%3.23%10.51%11.75%1 Year Performance185.58%7.28%34.39%18.02% Microbot Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBOTMicrobot Medical2.2087 of 5 stars$2.97+8.4%$9.00+203.0%+200.0%$99.68MN/A-4.5720OMOutset Medical1.5534 of 5 stars$18.81-3.0%$29.50+56.8%-66.7%$333.31M$113.69M-0.65520Positive NewsCLPTClearPoint Neuro2.1264 of 5 stars$11.85+3.9%$25.00+111.0%+48.5%$331.68M$31.39M-15.59110News CoverageRXSTRxSight2.4454 of 5 stars$7.74-3.3%$23.90+208.8%-82.4%$314.53M$148.31M-11.55220Trending NewsNPCENeuroPace3.4431 of 5 stars$9.55+0.3%$15.50+62.3%+10.6%$313.23M$84.31M-11.37170Positive NewsSNWVSanuwave HealthN/A$36.16+4.0%N/AN/A$309.39M$36.19M-7.9440Positive NewsNNOXNano-X Imaging1.9306 of 5 stars$5.15+1.8%$9.50+84.5%-33.8%$297.57M$11.28M-5.72190News CoveragePositive NewsCATXPerspective Therapeutics2.37 of 5 stars$4.00+0.5%$12.56+213.9%-70.2%$296.91MN/A0.0070News CoverageDRTSAlpha Tau Medical2.8445 of 5 stars$3.23+5.6%$8.00+147.7%+44.0%$273.97MN/A-7.0280Positive NewsNYXHNyxoah2.5015 of 5 stars$7.84+3.7%$14.50+84.9%-10.6%$267.03M$4.36M-3.68110Positive NewsXAIRBeyond Air4.5544 of 5 stars$3.05-11.6%$1.50-50.8%-74.5%$263.43M$3.70M-3.8670High Trading Volume Related Companies and Tools Related Companies Outset Medical Alternatives ClearPoint Neuro Alternatives RxSight Alternatives NeuroPace Alternatives Sanuwave Health Alternatives Nano-X Imaging Alternatives Perspective Therapeutics Alternatives Alpha Tau Medical Alternatives Nyxoah Alternatives Beyond Air Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MBOT) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbot Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MBOT Stock Alerts